NCT00803062 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 111
- group Id
- BG003
- value
- 112
- group Id
- BG004
- value
- 452
- units
- Participants
- groups
- description
- Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG000
- title
- Arm I (Paclitaxel and Cisplatin)
- description
- Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG001
- title
- Arm II (Paclitaxel, Cisplatin, Bevacizumab)
- description
- Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Cycles repeated q21 days to progression/toxicity
- id
- BG002
- title
- Arm III (Topotecan Hydrochloride and Paclitaxel)
- description
- Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG003
- title
- Arm IV (Topotecan Hydrochloride, Paclitaxel, Bevacizumab)
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 18
- title
- 20-29 years
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 94
- title
- 30-39 years
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 41
- group Id
- BG004
- value
- 144
- title
- 40-49 years
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 116
- title
- 50-59 years
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 56
- title
- 60-69 years
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 19
- title
- 70-79 years
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 5
- title
- 80-89 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 111
- group Id
- BG003
- value
- 112
- group Id
- BG004
- value
- 452
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- All enrolled patients.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 111
- group Id
- BG003
- value
- 112
- group Id
- BG004
- value
- 452
- units
- Participants
- groups
- description
- Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG000
- title
- Arm I (Paclitaxel and Cisplatin)
- description
- Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG001
- title
- Arm II (Paclitaxel, Cisplatin, Bevacizumab)
- description
- Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Cycles repeated q21 days to progression/toxicity
- id
- BG002
- title
- Arm III (Topotecan Hydrochloride and Paclitaxel)
- description
- Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity
- id
- BG003
- title
- Arm IV (Topotecan Hydrochloride, Paclitaxel, Bevacizumab)
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 18
- title
- 20-29 years
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 94
- title
- 30-39 years
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 33
- group Id
- BG003
- value
- 41
- group Id
- BG004
- value
- 144
- title
- 40-49 years
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 116
- title
- 50-59 years
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 56
- title
- 60-69 years
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 19
- title
- 70-79 years
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 5
- title
- 80-89 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 114
- group Id
- BG001
- value
- 115
- group Id
- BG002
- value
- 111
- group Id
- BG003
- value
- 112
- group Id
- BG004
- value
- 452
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- All enrolled patients.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle